PRDX6 Promotes Fatty Acid Oxidation via PLA2-Dependent PPARα Activation in Rats Fed High-Fat Diet
Antioxidants & Redox Signaling · 2023-06 · 38 (16-18) · 1184-1200
DOI: 10.1089/ars.2022.0065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, online erschienen am 25.05.2023. Verfasst von Wenwen Shen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Aims
Nonalcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease globally, which is defined as an excess accumulation of fat caused by the imbalance of lipogenesis and lipid catabolism. Recently, increasing evidence suggests that peroxiredoxin 6 (PRDX6) is involved in the pathogenesis and progression of NAFLD. However, little is known regarding its role in liver lipid catabolism.
Results
We found that PRDX6 level was significantly increased in liver tissues after high-fat diet (HFD) treatment. PRDX6 knockout (KO) exacerbated HFD-induced hepatic steatosis. PRDX6 KO did not affect messenger RNA (mRNA) and protein levels of peroxisome proliferator-activated receptor alpha (PPARα). However, PRDX6 KO decreased the mRNA and protein levels of carnitine palmitoyltransferase-1alpha (CPT-1α) and acyl-CoA oxidase 1 (ACOX1), the target genes of PPARα. PRDX6 KO also did not activate AMP-activated protein kinase (AMPK)α/proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α), the upstream signal of PPARα. However, PRDX6 KO reduces the levels of PPARα activators, the oxidized fatty acids (9- and 13-hydroxyoctadecadienoic acid) in HFD rats. More interestingly, PRDX6 promoted the production of oxidized fatty acids by hydrolyzing oxidized low-density lipoprotein (Ox-LDL), which depends on its phospholipase A2 (PLA2) activity. PRDX6 mutation on its PLA2 and its competitive phospholipase inhibitor inhibited the production of the oxidized fatty acids as well as the activation of PPARα. Furthermore, PRDX6 overexpression enhanced the transcriptional activation of PPARα. Innovation and Conclusion: This study elucidates for the first time the role of PLA2 enzyme activity of PRDX6 in fatty acid oxidation and reveals a novel mechanism of PRDX6 involved in liver steatosis. Antioxid. Redox Signal. 38, 1184–1200.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
- Biopharmaceutical Research Institute, Anhui Medical University, Hefei, China.
- Anhui Medical University, Center for Scientific Research of Anhui Medical University, Hefei, China.
ORCID-Profile: Yuxian Shen
Zitieren
APA
Shen, W., Yang, L., Yang, Y., Wang, P., Tao, X., Shen, Y., Wang, S., & Shen, Y. (2023). PRDX6 Promotes Fatty Acid Oxidation via PLA2-Dependent PPARα Activation in Rats Fed High-Fat Diet. Antioxidants & Redox Signaling, 38(16-18), 1184-1200. https://doi.org/10.1089/ars.2022.0065
Vancouver
Shen W, Yang L, Yang Y, Wang P, Tao X, Shen Y, et al. PRDX6 Promotes Fatty Acid Oxidation via PLA2-Dependent PPARα Activation in Rats Fed High-Fat Diet. Antioxidants & Redox Signaling. 2023;38(16-18):1184-1200. doi:10.1089/ars.2022.0065
BibTeX
@article{Shen2023,
author = {Shen, Wenwen and Yang, Lin and Yang, Yi and Wang, Peng and Tao, Xiaofang and Shen, Yujun and Wang, Sheng and Shen, Yuxian},
title = {PRDX6 Promotes Fatty Acid Oxidation via PLA2-Dependent PPARα Activation in Rats Fed High-Fat Diet},
journal = {Antioxidants & Redox Signaling},
year = {2023},
volume = {38},
number = {16-18},
pages = {1184--1200},
doi = {10.1089/ars.2022.0065}
}
EUVIMED